DOCSLIB.ORG

Subject Index

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Subject Index Cambridge University Press 0521462924 - Amino Acids and Peptides G. C. Barrett and D. T. Elmore Index More information Subject index acetamidomalonate synthesis 123–4 in fossil dating 15 S-adenosyl--methionine 11, 12, 174, 181 in geological samples 15 alanine, N-acetyl 9 in Nature 1 structure 4 IR spectrometry 36 alkaloids, biosynthesis from amino acids 16–17 isolation from proteins 121 alloisoleucine 6 mass spectra 61 allosteric change 178 metabolism, products of 187 allothreonine 6 metal-binding properties 34 Alzheimer’s disease 14 NMR 41 amidation at peptide C-terminus 57, 94, 181 physicochemical properties 32 amides, cis–trans isomerism 20 protein 3 N-acylation 72 PTC derivatives 87 N-alkylation 72 quaternary ammonium salts 50 hydrolysis 57 reactions of amino group 49, 51 O-trimethylsilylation 72 reactions of carboxy group 49, 53 reduction to ␤-aminoalkanols 72 racemisation 56 amidocarbonylation in amino acid synthesis 125 routine spectrometry 35 amino acids, abbreviated names 7 Schöllkopf synthesis 127–8 acid–base properties 32 Schiff base formation 49 antimetabolites 200 sequence determination 97 et seq. as food additives 14 following selective chemical degradation 107 as neurotransmitters 17 following selective enzymic degradation 109 asymmetric synthesis 127 general strategy for 92 ␤- 17–18 identification of C-terminus 106–7 biosynthesis 121 identification of N-terminus 94, 97 biosynthesis from, of creatinine 183 by solid-phase methodology 100 of nitric oxide 186 by stepwise chemical degradation 97 of porphyrins 185 by use of dipeptidyl aminopeptidase 105 of ribonucleotides 183 by stepwise enzymic degradation 105 of urea 185 racemisation during 103 biotechnological synthesis 121 of genetically abnormal proteins 112 circular dichroism 40 sources and roles 1 conjugation with other compounds 182 sources of information xiv–xv, 19 - 13–14 stereoselective synthesis 127 definitions 1 synthesis 120 derivatisation 58 Bucherer–Bergs 123–4 extra-terrestrial distribution 15 by carbonylation of alkylamides 123 ␥- 17 from coded amino acids 122 Gabriel synthesis 125 from diethyl acetamidomalonate 124 GLC 85 from glycine derivatives 123 220 © Cambridge University Press www.cambridge.org Cambridge University Press 0521462924 - Amino Acids and Peptides G. C. Barrett and D. T. Elmore Index More information Subject index Strecker 123–4 structure 10 thin-layer chromatography 59 cysteine, structure 5 trivial names 4–6 unusual 11 dansylamino acids 58–9 UV spectrometry 37 dehydroalanine 8 UV fluorescence spectrometry 37 denaturing of peptides 29–30 ␣-amino group protection 134 deoxyribonucleic acid, sequence determination of aminoisobutyric acid 120 116 aminoacylRNAs 3 depsipeptides, definition 3 aminoadipic acid 18 derivatisation of amino acids for analysis 58 aminolaevulinic acid 18 diethoxypiperazines 128 aminophosphonic acids 2 dimethylvaline in dolastatin 15, 67 aminosulphonic acids 2 dipeptides, conformations 21, 26 amphiphilic oligopeptides 28 disulphide bonds angiotensin II, mechanism of generation 203 determination of position of 112 angiotensin-converting enzyme (ACE) 203 exchange reactions of 112 antibodies, epitopes of 213 formation from cysteine 8 production of 213 methods of cleaving 96 anthrax spore, poly(-glutamic acid) content 3 methods for forming 170 arginine, structure 4 types in peptides and proteins 91 asparagine, structure 4 dityrosine 8 aspartic acid, N-methyl-- 14 DNA sequence determination 116 side-chain reactions 122–3 dolastatin 15, structure determination 67 structure 4 domain 27 azapeptides 211 -Dopa 12 azetidine-2-carboxylic acid 13 dopamine 12 azlactones (see also oxazolones) 53, 124 asymmetric hydrogenation 128 Edman sequencing 57, 70, 77, 97 enantiomeric analysis of amino acids 59 Barrett representation, -amino acid 4 enkephalins 2, 212 ␤-bends and ␤-turns 24 enniatins 3 bestatin 18 enzymes, quaternary structure 28 bradykinin 213 epidermal growth factor (EGF) 202 mass spectrum 73 essential amino acids 13 bradykinin analogue, conformation 26 extended conformation of peptide 21 Bucherer–Bergs synthesis of amino acids 123–4 fast atom bombardment MS 75 ␥-carboxyglutamic acid 12, 124 Fischer projection, -amino acid 4, 9 ␣-carboxy-group protection 135 fluoresceamine derivatives of amino acids 58–9 carboxylation of amino acid side-chain 8 Fmoc amino acids carnitine 18 in analysis 58–9 cell adhesion peptide 24, 27 in peptide synthesis 135 chemical ionisation MS 75 folic acid 200 Chou–Fasman rules for CD 41 cis-peptide bonds 21 GABA 17 citrulline 8 Gabriel synthesis of amino acids 125 coded amino acids 3 genetic code 175 combinatorial synthesis of peptides 215 globular proteins 28 conformations of peptides 20 glutamic acid transitions between 29 side-chain reactions 122–3 N-methyl peptides 25 structure 4 crosslinks in peptides and proteins (see also glutamine disulphide bonds) 92 side-chain methylation 8 crosslinking amino acids 8, 92 structure 4 Curtius rearrangement, in amino acid synthesis glutathione 2 123, 125 biosynthesis of 190 cyclic peptides in biosynthesis of leukotriene derivatives 192 homodetic 10, 26, 168 glycine heterodetic 170 in interstellar dust clouds 15 cyclosporin A 92 structure 4 221 © Cambridge University Press www.cambridge.org Cambridge University Press 0521462924 - Amino Acids and Peptides G. C. Barrett and D. T. Elmore Index More information Subject index glycosylated amino acids 8 methylvaline in dolastatin 15, 67 glycylglycine, formation 7 microcystins 18, 44 gramicidin S analogues, conformation 25 Miller–Urey amino acid synthesis 123 gramicidins, MS 75 Mitsunobu reaction with serine 122 helicogenic amino acids 22–3 N-blocked peptides, MS sequencing 70 ␣-helix 24 N-methyl--aspartic acid 14 CD 36, 39 ninhydrin reaction of amino acids 52, 184 ␣-helix-promoting amino acids, see helicogenic nerve-growth factor (NGF) 202 amino acids NMR 41 histidine, structure 5 nomenclature of amino acids and peptides 4–7 hydantoin synthesis 123–4 norleucine 13 hydantoinase in asymmetric synthesis, amino nylon(2) 3 acids 127 hydrophilicity 4 oligopeptide, definition 2 hydrophobicity 4 one-letter names for amino acids 4–5, 7–8 hydroxy acids 3 OPA derivatives of amino acids 58–9 hydroxyproline structure 8 organoboron amino acids 2 hydroxyvaline in dolastatin 15, 67 ornithine 8, 17 orthogonal group protection, in peptide synthesis imino acids 3–4 132 instrumentation for MS 75 oxazol-5(4H)-ones (see also azlactones) 124, 128 insulin 2, 10, 25, 178, 203 oxytocin 201 formation from proinsulin 11 structure 10 Parkinson’s disease 12 iodo--alanine 122 partial hydrolysis of peptides 57, 72 IR spectrometry 36 penicillins and cephalosporins, biosynthesis from isoleucine, structure 4 tripeptide 16, 192 isopeptides 2 pepstatin 205 isopenicillin N synthase (IPNS) 194 peptide antibiotics 217 IUPAC–IUB nomenclature rules 5 peptide bonds evidence for in peptides and proteins 91 kainic acid 12 formation using acid anhydrides 151 lanthionine 8 using acid chlorides and fluorides 151 leucine, structure 4 using acyl azides 150 lysine using carbodiimides 153 side-chain acylation 8 using phosphonium and isouronium side-chain methylation 8 derivatives 155 structure 5 using reactive esters 153 lysinoalanine 8 peptide hormones 201 lysozyme 28 azapeptide analogues of 211 biosynthesis of 212 Marfey’s reagent 44, 59 retropeptide analogues of 211 Maillard reaction 53 thionopeptide analogues of 210 mass spectra peptide synthesis, and genetic engineering 132 amino acids 61 enantiomerisation during, mechanisms of 146 peptides 62 methods of quantification 148 interpretation 65 principles and strategy 130 derivatised peptides 71 using enzymes for 164 MeBmt in cyclosporin 10 using solid-phase supports (SPPS) 156 melittin, MS 75–6 apparatus for 163 metastable peaks in mass spectra 68 linkers for 158 methionine using a soluble handle 163 S-oxidation 8 peptides S-alkylation 8 abbreviated names 7 structure 5 acid–base properties 32 methionyl bonds, selective cleavage of 107 circular dichroism 39–40 methotrexate 201 cyclic 10, 26, 168 methylDOPA 120 C-terminal esterification 71 222 © Cambridge University Press www.cambridge.org Cambridge University Press 0521462924 - Amino Acids and Peptides G. C. Barrett and D. T. Elmore Index More information Subject index definitions 2 role of amino acids 175 derivatisation for MS 71 role of messenger RNA (mRNA) 176 enzyme-linked immunosorbent assays role of transfer RNA (tRNA) 176 (ELISAs) for 88 protein, definition 2 fragmentation after electron impact 62 proteinases general sources of information xiv–xv, 19 inhibitors 204 IR spectrometry 36 mechanism of action 204 mass spectra 62 et seq. proteins, post-translational changes 11, 178 metal-binding properties 34 PTC amino acids in analysis 58 N-terminal acylation 71 PTH derivatives of amino acids 60 NMR 41–7 primary structure 27, 29, 91 et seq. radioimmunoassay methods for 87 quaternary structure 28 reactions of amino group 49, 51 quisqualic acid 12 reactions of carboxy group 49, 53 routine spectrometry 35 R/S convention 5 secondary structure 27 racemisation, amino acids in fossils 15–16 tertiary structure 27 racemisation kinetics, amino acids 15 UV spectrometry 37 racemisation of amino acids 15, 56 UV fluorescence spectrometry 37 random conformation, CD 39, 42 peptoids 3 renin 203 phenylalanine, structure 5 resolution of -amino acids 125 phosphate esters of amino acids 8 retropeptides 211 platelet-derived growth factor (PDGF) 202 poly(amide)s, definition 3 Schiff base alkylation in amino acid synthesis 123 poly(amino acid)s, definition 3 Schiff base formation from amino acids
Load more

Recommended publications
  • A Few Experimental Suggestions Using Minerals to Obtain Peptides with a High Concentration of L-Amino Acids and Protein Amino Acids
    S S symmetry Hypothesis A Few Experimental Suggestions Using Minerals to Obtain Peptides with a High Concentration of L-Amino Acids and Protein Amino Acids Dimas A. M. Zaia 1,* and Cássia Thaïs B. V. Zaia 2 1 Laboratório de Química Prebiótica-LQP, Departamento de Química, Universidade Estadual de Londrina, CEP 86 057-970 Londrina, Brazil 2 Laboratório de Fisiologia Neuroendocrina e Metabolismo–LaFiNeM, Departamento de Ciências Fisiológicas, Universidade Estadual de Londrina, CEP 86 057-970 Londrina, Brazil; [email protected] * Correspondence: [email protected] Received: 9 October 2020; Accepted: 25 November 2020; Published: 10 December 2020 Abstract: The peptides/proteins of all living beings on our planet are mostly made up of 19 L-amino acids and glycine, an achiral amino acid. Arising from endogenous and exogenous sources, the seas of the prebiotic Earth could have contained a huge diversity of biomolecules (including amino acids), and precursors of biomolecules. Thus, how were these amino acids selected from the huge number of available amino acids and other molecules? What were the peptides of prebiotic Earth made up of? How were these peptides synthesized? Minerals have been considered for this task, since they can preconcentrate amino acids from dilute solutions, catalyze their polymerization, and even make the chiral selection of them. However, until now, this problem has only been studied in compartmentalized experiments. There are separate experiments showing that minerals preconcentrate amino acids by adsorption or catalyze their polymerization, or separate L-amino acids from D-amino acids. Based on the [GADV]-protein world hypothesis, as well as the relative abundance of amino acids on prebiotic Earth obtained by Zaia, several experiments are suggested.
    [Show full text]
  • Ratio of Phosphate to Amino Acids
    National Institute for Health and Care Excellence Final Neonatal parenteral nutrition [D10] Ratio of phosphate to amino acids NICE guideline NG154 Evidence reviews February 2020 Final These evidence reviews were developed by the National Guideline Alliance which is part of the Royal College of Obstetricians and Gynaecologists FINAL Error! No text of specified style in document. Disclaimer The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian. Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties. NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive.
    [Show full text]
  • Proteins, Peptides, and Amino Acids
    Proteins, Peptides, and Amino Acids Chandra Mohan, Ph.D. Calbiochem-Novabiochem Corp., San Diego, CA The Chemical Nature of Amino Acids Peptides and polypeptides are polymers of α-amino acids. There are 20 α-amino acids that make-up all proteins of biological interest. The α-amino acids in peptides and proteins α consist of a carboxylic acid (-COOH) and an amino (-NH2) functional group attached to the same tetrahedral carbon atom. This carbon is known as the -carbon. The type of R- group attached to this carbon distinguishes one amino acid from another. Several other amino acids, also found in the body, may not be associated with peptides or proteins. These non-protein-associated amino acids perform specialized functions. Some of the α-amino acids found in proteins are also involved in other functions in the body. For example, tyrosine is involved in the formation of thyroid hormones, and glutamate and aspartate act as neurotransmitters at fast junctions. R Amino acids exist in either D- or L- enantiomorphs or stereoisomers. The D- and L-refer to the absolute confirmation of optically active compounds. With the exception of glycine, all other amino acids are mirror images that can not be superimposed. Most of the amino acids found in nature are of the L-type. Hence, eukaryotic proteins are always composed of L-amino acids although D-amino acids are found in bacterial cell walls and in some peptide antibiotics. All biological reactions occur in an aqueous phase. Hence, it is important to know how the R-group of any given amino acid dictates the structure-function relationships of peptides and proteins in solution.
    [Show full text]
  • COMPILATION of AMINO ACIDS, DRUGS, METABOLITES and OTHER COMPOUNDS in MASSTRAK AMINO ACID ANALYSIS SOLUTION Paula Hong, Kendon S
    COMPILATION OF AMINO ACIDS, DRUGS, METABOLITES AND OTHER COMPOUNDS IN MASSTRAK AMINO ACID ANALYSIS SOLUTION Paula Hong, Kendon S. Graham, Alexandre Paccou, T homas E. Wheat and Diane M. Diehl INTRODUCTION LC conditions Physiological amino acid analysis is commonly performed to LC System: Waters ACQUITY UPLC® System with TUV monitor and study a wide variety of metabolic processes. A wide Column: MassTrak AAA Column 2.1 x 150 mm, 1.7 µm variety of drugs, foods, and metabolic intermediates that may Column Temp: 43 ˚C be present in biological fluids can appear as peaks in amino Flow Rate: 400 µL/min. acid analysis, therefore, it is important to be able to identify Mobile Phase A: MassTrak AAA Eluent A Concentrate, unknown compounds.1,2,3 The reproducibility and robustness of diluted 1:10 the MassTrak Amino Acid Analysis Solution make this method well Mobile Phase B: MassTrak AAA Eluent B suited to such a study as well.4 Weak Needle Wash: 5/95 Acetonitrile/Water Strong Needle Wash: 95/5 Acetonitrile/Water Gradient: MassTrak AAA Standard Gradient (as provided in kit) Detection: UV @ 260 nm Injection Volume: 1 µL EXPERIMENTAL Injection Mode: Partial Loop with Needle Overfill (PLNO) Compound sample preparation A library of compounds was assembled. Each compound was derivatized individually and spiked into the MassTrak™ AAA Solution Standard prior to chromatographic analysis. The elution RESULTS AND DISCUSSION position of each tested compound could be related to known amino acids. A wide variety of antibiotics, pharmaceutical compounds and metabolite by-products are found in biological fluids. The reten- 1.
    [Show full text]
  • Supplementary File 1 (PDF, 650 Kib)
    Preliminary Zinc and boscalid sub lethal concentrations Zinc and boscalid sub lethal concentrations were determined by running preliminary 72‐hour LC50 exposures. A range of concentrations, resulting in 100% survival to 100% mortality was run for both chemicals in water only exposures. Filtered seawater was used as a control and to dilute stock concentrations of zinc and boscalid. Six treatments with three replicates were run for both chemicals including a control (seawater only). The zinc chloride (ZnCl2) exposure concentrations were: 62mg/L; 125mg/L; 250mg/L; 500mg/L and 1000mg/L. The commercial fungicide Filan® has 500g/kg active ingredient of boscalid, concentrations of 100mg/L; 250mg/L; 500mg/L; 750mg/L and 1000mg/L. Acid‐ rinsed 600ml glass beakers were randomly placed in a temperature‐controlled incubator at 20oC (+/‐ 1oC) with added aeration and a one ply sheet of ethanol rinsed toilet paper in each beaker as substratum. No food was added; the average pH of the water was 7.5 across treatments. The dissolved oxygen remained between 70‐100%. Zinc chloride LC50 = 125mg/L and boscalid LC50 = 750mg/L. Table S1. –Concentrations of boscalid and zinc at 0 h and one week. Measured concentrations of boscalid and zinc detected in estuaries in Victoria, Australia. Exposure at Control Exposure at 0 hr Environmental dose 1 week Boscalid 0 N/A 75 mg/L 3.3 mg/L (Vu et al. 2016) Zinc 0.026 – 0.034 mg/L 12.5 mg/L 3.4 mg/L (Long et al. 2015) Table S2. Water Quality Parameters. Date Sample Dissolved oxygen (%) pH Conductivity (µS/cm) Ammonia 15/05/17 Control 98.36 8.44 59464.4 0.25 15/05/17 Zinc 99.10 8.31 59379.1 0.25 15/05/17 Boscalid 99.18 8.28 59656.8 0.25 15/05/17 Mixture 94.81 8.25 59386.0 0.25 30/05/17 Control 101.90 8.16 59332.4 0.5 30/05/17 Zinc 102.47 8.11 59536.7 0.5 30/05/17 Boscalid 92.17 8.15 59489.3 0.5 30/05/17 Mixture 101.57 8.14 59593.2 0.5 Supplementary Material .
    [Show full text]
  • Vitamin K Dependent Modifications of Glutamic Acid Residues In
    Proc. Nat. Acad. Sci. USA Vol. 71, No. 7, pp. 2730-2733, July 1974 Vitamin K Dependent Modifications of Glutamic Acid Residues in Prothrombin (proton magnetic resonance spectroscopy/mass spectrometry) JOHAN STENFLO*, PER FERNLUND*, WILLIAM EGANt, AND PETER ROEPSTORFFt * Department of Clinical Chemistry, University of Lund, Malm6 General Hospital, 8-214 01 Malm6, Sweden; t Department of Physical Chemistry II, Lund Institute of Technology, Chemical Center, S-220 07 Lund, Sweden; and t The Danish Institute of Protein Chemistry, DK-2970 Horsholm, Denmark Communicated by Sune Bergstrom, May 9, 1974 ABSTRACT A tetrapeptide, residues 6 to 9 in normal hydrogen on the -y carbon atom by a carboxyl group. This prothrombin, was isolated from the NH2-terminal, Ca2+- work will be described in greater detail elsewhere. binding part of normal prothrombin. The electrophoretic mobility of the peptide was too high to be explained en- tirely by its amino-acid composition. According to 1H MATERIALS AND METHODS nuclear magnetic resonance spectroscopy and mass Isolation of Tetrapeptide. The heptapeptide from normal spectrometry, the peptide contained two residues of modi- fied glutamic acid, -y-carboxyglutamic acid (3-amino-1,1,3- prothrombin (residues 4 to 10) (ref. 13) was first thoroughly propanetricarboxylic acid), a hitherto unidentified amino digested with aminopeptidase M (Sigma) and afterwards with acid. This amino acid gives normal prothrombin the Ca2 +_ carboxypeptidase B (Sigma). A tetrapeptide was isolated binding ability that is necessary for its activation. Obser- from the digest by gel chromatography on Sephadex G-25 vations indicate that abnormal prothrombin, induced by the vitamin K antagonist, dicoumarol, lacks these modi- superfine and obtained in pure form as judged by high voltage fied glutamic acid residues and that this is the reason why electrophoresis at pH 6.5 (electrophoretic mobility relative to abnormal prothrombin does not bind Ca2+ and is non- that of aspartic acid 1.09) and amino-acid analysis (14), which functioning in blood coagulation.
    [Show full text]
  • N,N-Diprotected Dehydroamino Acid Derivatives: Versatile Substrates for the Synthesis of Novel Amino Acids
    N,N-DIPROTECTED DEHYDROAMINO ACID DERIVATIVES: VERSATILE SUBSTRATES FOR THE SYNTHESIS OF NOVEL AMINO ACIDS Paula M. T. Ferreira and Luís S. Monteiro Department of Chemistry, University of Minho, Gualtar, 4710-057 Braga, Portugal (e-mail: [email protected]) Abstract. Non-proteinogenic amino acids are an important class of organic compounds that can have intrinsic biological activity or can be found in peptides with antiviral, antitumor, anti-inflammatory or immunosuppressive activities. This type of compounds is also important in drug development, in the elucidation of biochemical pathways and in conformational studies. Therefore, research towards efficient methods that allow the synthesis of these compounds constitutes an important area of peptide chemistry. In our laboratories we have developed a new and high yielding method for the synthesis of N,N-diprotected dehydroamino acid derivatives using tert-butyl pyrocarbonate and 4-dimethylaminopyridine. These compounds were used as substrates in several types of reactions, allowing the synthesis of a variety of new amino acid derivatives. Some of these new compounds are heterocyclic systems or contain heterocyclic moieties such as pyrazole, indole, or imidazole. Thus, several nitrogen heterocycles were reacted with N,N-diprotected dehydroalanine to give new β-substituted alanines and dehydroalanines. Furanic amino acids were obtained treating the methyl ester of N-(4-toluenesulfonyl), N-(tert-butoxycarbonyl) dehydroalanine with carbon nucleophiles of the β-dicarbonyl type having at least one methyl group attached to one of the carbonyl groups. Treatment of these furanic amino acids with trifluoracetic acid afforded pyrrole derivatives in good to high yields. A N,N-diprotected 1,4-dihydropyrazine was obtained reacting the methyl ester of N-(4-toluenesulfonyl), N-(tert-butoxycarbonyl)dehydroalanine with 4-dimethylaminopyridine and an excess of potassium carbonate.
    [Show full text]
  • Dissociation Constants of Organic Acids and Bases
    DISSOCIATION CONSTANTS OF ORGANIC ACIDS AND BASES This table lists the dissociation (ionization) constants of over pKa + pKb = pKwater = 14.00 (at 25°C) 1070 organic acids, bases, and amphoteric compounds. All data apply to dilute aqueous solutions and are presented as values of Compounds are listed by molecular formula in Hill order. pKa, which is defined as the negative of the logarithm of the equi- librium constant K for the reaction a References HA H+ + A- 1. Perrin, D. D., Dissociation Constants of Organic Bases in Aqueous i.e., Solution, Butterworths, London, 1965; Supplement, 1972. 2. Serjeant, E. P., and Dempsey, B., Ionization Constants of Organic Acids + - Ka = [H ][A ]/[HA] in Aqueous Solution, Pergamon, Oxford, 1979. 3. Albert, A., “Ionization Constants of Heterocyclic Substances”, in where [H+], etc. represent the concentrations of the respective Katritzky, A. R., Ed., Physical Methods in Heterocyclic Chemistry, - species in mol/L. It follows that pKa = pH + log[HA] – log[A ], so Academic Press, New York, 1963. 4. Sober, H.A., Ed., CRC Handbook of Biochemistry, CRC Press, Boca that a solution with 50% dissociation has pH equal to the pKa of the acid. Raton, FL, 1968. 5. Perrin, D. D., Dempsey, B., and Serjeant, E. P., pK Prediction for Data for bases are presented as pK values for the conjugate acid, a a Organic Acids and Bases, Chapman and Hall, London, 1981. i.e., for the reaction 6. Albert, A., and Serjeant, E. P., The Determination of Ionization + + Constants, Third Edition, Chapman and Hall, London, 1984. BH H + B 7. Budavari, S., Ed., The Merck Index, Twelth Edition, Merck & Co., Whitehouse Station, NJ, 1996.
    [Show full text]
  • Phenotype Microarrays™
    Phenotype MicroArrays™ PM1 MicroPlate™ Carbon Sources A1 A2 A3 A4 A5 A6 A7 A8 A9 A10 A11 A12 Negative Control L-Arabinose N-Acetyl -D- D-Saccharic Acid Succinic Acid D-Galactose L-Aspartic Acid L-Proline D-Alanine D-Trehalose D-Mannose Dulcitol Glucosamine B1 B2 B3 B4 B5 B6 B7 B8 B9 B10 B11 B12 D-Serine D-Sorbitol Glycerol L-Fucose D-Glucuronic D-Gluconic Acid D,L -α-Glycerol- D-Xylose L-Lactic Acid Formic Acid D-Mannitol L-Glutamic Acid Acid Phosphate C1 C2 C3 C4 C5 C6 C7 C8 C9 C10 C11 C12 D-Glucose-6- D-Galactonic D,L-Malic Acid D-Ribose Tween 20 L-Rhamnose D-Fructose Acetic Acid -D-Glucose Maltose D-Melibiose Thymidine α Phosphate Acid- -Lactone γ D-1 D2 D3 D4 D5 D6 D7 D8 D9 D10 D11 D12 L-Asparagine D-Aspartic Acid D-Glucosaminic 1,2-Propanediol Tween 40 -Keto-Glutaric -Keto-Butyric -Methyl-D- -D-Lactose Lactulose Sucrose Uridine α α α α Acid Acid Acid Galactoside E1 E2 E3 E4 E5 E6 E7 E8 E9 E10 E11 E12 L-Glutamine m-Tartaric Acid D-Glucose-1- D-Fructose-6- Tween 80 -Hydroxy -Hydroxy -Methyl-D- Adonitol Maltotriose 2-Deoxy Adenosine α α ß Phosphate Phosphate Glutaric Acid- Butyric Acid Glucoside Adenosine γ- Lactone F1 F2 F3 F4 F5 F6 F7 F8 F9 F10 F11 F12 Glycyl -L-Aspartic Citric Acid myo-Inositol D-Threonine Fumaric Acid Bromo Succinic Propionic Acid Mucic Acid Glycolic Acid Glyoxylic Acid D-Cellobiose Inosine Acid Acid G1 G2 G3 G4 G5 G6 G7 G8 G9 G10 G11 G12 Glycyl-L- Tricarballylic L-Serine L-Threonine L-Alanine L-Alanyl-Glycine Acetoacetic Acid N-Acetyl- -D- Mono Methyl Methyl Pyruvate D-Malic Acid L-Malic Acid ß Glutamic Acid Acid
    [Show full text]
  • Isolation and Characterization of Vitamin K-Dependent Region Of
    Proc. Nat. Acad. Sci. USA Vol. 72, No. 4, pp. 1281-1285, April 1975 Isolation and Characterization of Vitamin K-Dependent Region of Bovine Blood Clotting Factor X (protein sequence/homology/calcium binding/-y-carboxyglutamic acid/coagulation) JAMES BRYANT HOWARD* AND GARY L. NELSESTUENt * Department of Biochemistry, College of Medicine 227 Millard Hall, University of Minnesota, Minneapolis, Minn. 55455; and t Department of Biochemistry, College of Biological Sciences, 140 Gortner Hall, University of Minnesota, St. Paul, Minn. 55101 Communicated by Emil L. Smith, January 17, 1975 ABSTRACT A 39-residue peptide from the tryptic di- that 8 of the 10 'y-carboxyglutamic acid residues are found in gestion of bovine blood clotting factor X has been isolated pairs (16, If the vitamin K-dependent blood clotting pro- by specific adsorption on barium citrate. The amino- and 1). carboxyl-terminal sequences of the peptide were deter- teins are related proteins, then homology between these mined and compared to the vitamin K-dependent Ca2+- proteins would be expected for the Ca2+-binding regions. We binding region from bovine prothrombin. The factor X wish to report the isolation and characterization of a peptide peptide was found to contain -y-carboxyglutamic acid resi- from factor X which is similar to the vitamin K-dependent, dues, and the results of independent analysis are con- sistent with all 14 glutamic acid residues as y-carboxy- Ca2+-binding region of prothrombin. Preliminary accounts of glutamic acid. The similarity of the factor X peptide to the some of this work have been presented (18, 20). prothrombin peptide supports the hypothesis that the vitamin K-dependent blood clotting proteins are de- METHODS AND MATERIALS scended from a common ancestral gene.
    [Show full text]
  • These Lanthionine FINALE
    FACULTÉ DES SCIENCES – DÉPARTEMENT DE CHIMIE CENTRE DE RECHERCHES DU CYCLOTRON SYNTHESIS AND BIOLOGICAL STUDIES OF LANTHIONINE DERIVATIVES Promoteur: Professeur André LUXEN Dissertation présentée par Thibaut DENOËL pour l’obtention du grade de Docteur en Sciences Année académique 2013 - 2014 Membres du Jury : Promoteur : Professeur André Luxen (Université de Liège) Président : Professeur Albert Demonceau (Université de Liège) Autres membres : Docteur Didier Blanot (Université Paris-Sud) Docteur David Thonon (Uteron Pharma) Professeur Bernard Joris (Université de Liège) Docteur Christian Lemaire (Université de Liège) Remerciements Les travaux présentés dans cette thèse ont été réalisés sous la direction du Professeur André Luxen dans les laboratoires du Centre de Recherches du Cyclotron de l’Université de Liège. Je voudrais tout d’abord remercier le Professeur André Luxen pour son accueil au sein du Cyclotron, sa grande patience et son exigence. Il a aussi inspiré nombre de manipulations et m’a guidé dans mes recherches. En outre, il a mis à ma disposition tout le matériel et la quantité de produits chimiques nécessaires à la réalisation de ce travail. Je tiens également à remercier Messieurs les membres du Jury pour m’avoir fait l’honneur d’accepter d’examiner ce travail, en l’occurrence le Docteur Didier Blanot (Université Paris-Sud), le Docteur David Thonon (Uteron Pharma), le Professeur Bernard Joris, le Docteur Christian Lemaire et le Professeur Albert Demonceau dans le rôle de Président. Je remercie aussi les Docteurs Didier Blanot et Mireille Hervé pour la réalisation des essais in vitro avec l’enzyme Mpl et l’aide dans les publications. Je remercie grandement le Docteur Astrid Zervosen pour la réalisation des manipulations biochimiques, ses conseils, sa disponibilité et la correction lors de la rédaction.
    [Show full text]
  • WO 2010/037397 Al
    (12) INTERNATIONALAPPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 8 April 2010 (08.04.2010) WO 2010/037397 Al (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 38/17 (2006.01) C07K 14/705 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 47/48 (2006.01) GOlN 33/50 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/DK2009/050257 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 1 October 2009 (01 .10.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every PA 2008 0 1381 1 October 2008 (01 .10.2008) DK kind of regional protection available): ARIPO (BW, GH, 61/101,898 1 October 2008 (01 .10.2008) US GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, (71) Applicant (for all designated States except US): DAKO TM), European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, DENMARK A/S [DK/DK]; Produktionsvej 42, DK-2600 ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, Glostrup (DK).
    [Show full text]